AP Pharma Inc.

Description

Company Profile A.P. Pharma, Inc. (NASDAQ NM: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments utilizing its proprietary polymer-based drug delivery systems.The Company's primary emphasis is on advancing its Biochronomer™ technology platform for site-specific and systemic drug delivery. Designed to release drugs over a period of hours, days, weeks or even months, Biochronomer systems can be fabricated into a wide range of solid and gel forms which erode as they deliver the drug.The Company's lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting is expected to enter a Phase 3 clinical trial in the second quarter of 2006. In addition, a variety of injectable and implantable applications are undergoing testing to address major unmet needs in pain management, inflammation, and DNA/RNAI applications.These FDA-approved products are based on the Company's original Microsponge® delivery system technology, which is used in numerous topical prescription and cosmeceutical products marketed worldwide. On January 18, 2006, the Company announced that it had sold the rights to future royalties to an affiliate of Paul Royalty Fund for up to $30 million.

Fact sheet

Company contacts

Products & services

Similar companies nearby